NIHR Performance Statistics

Published/updated: 24/04/14 14:07

The Trust is committed to providing an open and transparent service for the population we serve.  In addition, as part of the Government’s Plan for Growth published in March 2011 we are required to publish data related to our research activity.  We will be reporting on our research activity every three months and below you will see this will be listed under two headings – Performance in Initiating Research (i.e. the time it takes us to approve a trial and start recruiting our first patient) and Performance in Delivering Research (i.e. whether we meet our recruitment target in the set time)

Data is required for all clinical trials which have received NHS permission or are open in the previous 12 months. A clinical trial is defined using the categories of:

1)       Clinical trial of an investigational medicinal product

2)       Clinical investigation or other study of a medical device

3)       Combined trial of an investigational medicinal product and an investigational medical device

4)       Other clinical trial to study a novel intervention or randomised clinical trial to compare interventions in clinical practice

Performance in Initiating Research

This table shows the trials we approved in the last 12 months and if we entered the first patient into the trial within the 70 day target.  This information is for any trial, regardless of whether it is a commercial or non-commercial trial or whether it is adopted on to the portfolio or not.  There will be times when it is not possible to recruit a patient within 70 days and we are required to give a reason for this.  There are specific categories we can use for this:

1)       Relevant permissions delay and not granted in time e.g. REC, MHRA, R&D

2)       Study suspended by Sponsor

3)       Study closed by Sponsor

4)       Delays caused by Sponsor e.g. delay in provision of pharmacy manual, protocol amendments, delayed site initiation visit

5)       Staff availability issues at site

6)       No eligible patients seen during this reported period

7)       Eligible patients seen during the relevant period but did not consent to participate

8)       Contracting delays – with Sponsor, NHS provider

9)       Rare or very rare diseases (NIHR define this as a disease affecting less than 1 in 100,000 citizens)

10)   Other – describe

Performance in Delivering Research

This table shows the trials that were open in the last 12 months and whether we meet our recruitment target in the agreed time. This information is limited to commercial trials only whether it is adopted on to the NIHR portfolio or not. It does not include any commercial trials which have closed to recruitment in the last 12 months.

 

 Quarter 1 (2016/2017)

Performance in initiating research

Performance in delivering research

 Quarter 2 (2016/2017)

Performance in initiating research

Performance in delivering research

 Quarter 3  (2016/2017)

Performance in initiating research

Performance in delivering research

 Quarter 4  (2016/2017)

Performance in initiating research

Performance in delivering research

 Quarter 1  (2017/2018)

Performance in initiating research

Performance in delivering research

 Quarter 2  (2017/2018)

Performance in initiating research

Performance in delivering research

 Quarter 3  (2017/2018)

Performance in initiating research

Performance in delivering research

Quarter 4  (2017/2018)

Performance in initiating research

Performance in delivering research

Quarter 1  (2018/2019)

Performance in initiating research

Performance in delivering research

Quarter 2  (2018/2019)

Performance in initiating research

Performance in delivering research

Quarter 3  (2018/2019)

Performance in initiating research

Performance in delivering research

Quarter 4  (2018/2019)

Performance in initiating research 

Performance in delivering research 

Accessibility
Close Close